KOSDAQBatteries318410

Best Bristle Company

₩5,050▼ 3.81%2026-11-18 close
Market Cap
₩28.1B
Turnover
₩100M
Volume
20K
Shares out.
5.6M
PER
4.4×
PBR
0.3×
EPS
₩1,184
Dividend Yield
7.65%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩400 per share · Prices as of the 2026-11-18 close

01

Report overview

Toothbrush-material maker: profit recovery amid quarterly swings

Best Bristle Company's operating profit rose for three straight years through 2025, but a net loss attributable to controlling shareholders in Q3 2026 exposed renewed quarterly volatility.

  1. 1

    Operating profit in 2025 was KRW 6.19 billion, rising for three consecutive years from 2023, and the operating margin climbed from 4.2% in 2022 to 12.0% in 2025.

  2. 2

    Operating profit in Q3 2026 stayed positive at KRW 1.89 billion, but the company swung to a net loss attributable to controlling shareholders of KRW 2.03 billion, making non-operating items and taxes the next points to examine.

  3. 3

    Monofilament (toothbrush bristle) material accounts for about 60% of sales, while the exchange classifies the stock under secondary batteries and the disclosed business centers on oral-care materials.

  4. 4

    At the end of 2025 the debt-to-equity ratio was 15.2%, and controlling shareholders' equity of KRW 80.1 billion was slightly above total equity of KRW 80 billion.

  5. 5

    Controlling shareholders' net income over the last four quarters totals KRW 6.54 billion, but quarterly swings are wide, and the next checkpoints are the Q4 2026 preliminary results and the 2026 annual report.

02

Business structure

Best Bristle Company builds its business around monofilament material used in toothbrush bristles, with healthcare, fashion accessories, cosmetics and air filter materials alongside. Its quarterly filing describes three business segments: monofilament materials, healthcare and fashion accessories.

According to AlphaSquare's breakdown, monofilament accounts for 59.73% of sales, healthcare 18.30%, B2B fashion accessories 11.72%, cosmetics 3.90%, air filter materials 2.22% and other items 4.13%.

A securities firm's 2023 analysis put the materials segment at 77% of 2022 sales and beauty and healthcare at 23%, though classification bases differ, so direct comparison with today's mix is limited. Key subsidiaries include K&K, L&C Corporation and Common Plus.

Customers include global clients, toothbrush OEM makers, machinery producers and raw material suppliers, and the company works with them through joint development rather than solely proprietary development. The company says it holds core proprietary technology for producing toothbrush bristles.

Fashion accessories sell on a B2B basis, and the company said market diversification narrowed losses in that segment. Within oral care, graphene toothbrushes and electric toothbrushes drove the improvement in 2024.

The exchange classifies the stock under secondary batteries, but the disclosed business mix shows no direct link to battery materials.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩10.6B₩700M7.0%
2025Q4₩15.5B₩500M3.0%
2026Q1₩13.7B₩2.1B15.5%
2026Q2₩15.3B₩3.8B24.8%
2026Q3₩12.2B₩1.9B15.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩45.3B₩1.9B₩1.6B4.2%2.1%14.9%
2023₩53.6B₩4.5B₩5.9B8.3%7.7%14.5%
2024₩60.7B₩5.7B₩4.1B9.4%5.3%17.6%
2025₩51.6B₩6.2B₩5.5B12.0%6.9%15.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual revenue rose from KRW 45.3 billion in 2022 to KRW 53.6 billion in 2023 (up 18.4% year on year) and KRW 60.7 billion in 2024 (up 13.2%), then fell to KRW 51.6 billion in 2025 (down 14.9%). Across 2022 to 2025, 2024 was the largest year and 2022 the smallest.

Operating profit went from KRW 1.91 billion in 2022 to KRW 4.46 billion in 2023 (up 133.8%), KRW 5.73 billion in 2024 (up 28.4%) and KRW 6.19 billion in 2025 (up 8.1%), rising for three consecutive years from 2023. The operating margin moved from 4.2% to 8.3%, 9.4% and 12.0% over the same period.

In 2025 the margin rose even as revenue declined, which points to cost structure rather than scale as the main source of improvement.

Net income attributable to controlling shareholders was KRW 1.56 billion in 2022, KRW 5.94 billion in 2023 (up 281.4%), KRW 4.09 billion in 2024 (down 31.2%) and KRW 5.51 billion in 2025 (up 34.9%).

Operating profit rose in 2024 while controlling-shareholder net income fell, and the non-operating items behind that gap need to be checked in the annual report detail.

In 2023, controlling-shareholder net income of KRW 5.94 billion exceeded total net income including non-controlling interests of KRW 5.36 billion, which suggests non-controlling interests absorbed a loss.

In quarterly terms, Q4 2025 revenue rose to KRW 15.5 billion (up 46.6% from the prior quarter), but operating profit fell to KRW 467 million (down 37.2%) and controlling-shareholder net income to KRW 108 million (down 92.6%). Operating profit recovered to KRW 2.12 billion in Q1 2026 and KRW 3.79 billion in Q2 2026.

In Q3 2026, revenue was KRW 12.2 billion (down 20.5% from the prior quarter and up 14.9% year on year), operating profit was KRW 1.89 billion (down 50.3% from the prior quarter), and the company recorded a controlling-shareholder net loss of KRW 2.03 billion, turning from profit to loss.

05

Industry analysis

The exchange classifies the stock under secondary batteries, but the disclosed business is centered on oral-care materials such as toothbrush bristles. For that reason, battery-materials cycle indicators are not a direct guide to this company's earnings.

Toothbrush bristle demand is linked to finished toothbrush demand and OEM orders, and the company says it co-develops with global clients, toothbrush OEM makers, machinery producers and raw material suppliers. In that structure, client product development schedules and order flow determine the timing of revenue.

The company points to its proprietary bristle production technology as the basis of its competitiveness. In healthcare, graphene and electric toothbrushes were cited as growth drivers, and fashion accessories are expanding through B2B sales.

Share or sales comparisons with specific competitors cannot be drawn from the disclosed figures, so the peer position is best read qualitatively.

The cycle position in oral care depends on finished toothbrush demand and overseas client orders, so client-level revenue trends in the coming quarters will be the main input for judging the industry backdrop.

06

Outlook

The company's direction appears to be keeping the co-development model in toothbrush bristle materials while enlarging the healthcare and fashion accessories segments.

Operating profit recovered in Q1 and Q2 2026, but in Q3 2026 it fell 50.3% from the prior quarter and the controlling-shareholder result turned to a net loss. The next checkpoints are therefore whether the operating profit recovery holds and how much non-operating items and income taxes weigh on net income.

The Q4 2026 preliminary results are expected around mid-February 2027, based on the precedent that the 2025 annual preliminary figures were disclosed on February 12, 2026.

The 2026 annual report is expected around late March 2027, when segment revenue, major clients and annual controlling-shareholder net income will be confirmed. The 2026 annual general meeting was held on March 31, 2026, and the financial statements were approved. The Q1 2027 quarterly report is due around mid-May 2027.

Across these three points, the key tests are whether the operating margin returns to the 12.0% level of 2025, whether client concentration declines, and whether controlling-shareholder net income moves in the same direction as operating profit. For now, the direction change in quarterly results matters more than any single annual number.

07

Valuation

PER
4.4×
PBR
0.3×
ROE
8.0%
EPS
₩1,184
BPS
₩15,078
Dividend per share
₩400

Valuation can be read through the relationship between share price, book value, earnings and dividends. Controlling-shareholder net income over the last four quarters is positive, so earnings-based multiples can be computed, but the Q3 2026 net loss means quarterly earnings swing sharply.

The price-to-book ratio sits below 1x, so the share price is under book equity. Market capitalization is smaller than total equity on the balance sheet.

A June 2023 research note from Korea Investor Relations Consortium described the forward PER estimates of that time as near the lower end of the historical range; that is a past assessment and cannot be compared directly with today's band.

In AlphaSquare's industry comparison, the dividend yield ranks above the industry average. Dividends can move with earnings, so their sustainability should be read alongside the earnings trend.

The structure in which controlling-shareholder equity of KRW 80.1 billion sits just above total equity of KRW 80 billion points to a stable book-value base.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Steady operating margin improvement

Operating margin rose from 4.2% in 2022 to 8.3% in 2023, 9.4% in 2024 and 12.0% in 2025. In 2025 operating profit still grew 8.1% even though revenue fell 14.9%. In 2024 the company attributed the improvement to graphene and electric toothbrush growth within oral care.

Profit rebound in the first half of 2026

Operating profit rose to KRW 2.12 billion in Q1 2026 and KRW 3.79 billion in Q2 2026. Controlling-shareholder net income stayed positive at KRW 3.13 billion and KRW 5.34 billion in those quarters. Compared with the KRW 108 million recorded in Q4 2025, the recovery is pronounced.

Low-burden capital structure

At the end of 2025, total liabilities were KRW 12.1 billion and total equity was KRW 80 billion. The debt-to-equity ratio fell from 17.6% in 2024 to 15.2% in 2025. Operating cash flow rose from KRW 3.73 billion in 2024 to KRW 11.3 billion in 2025, improving alongside earnings.

09

Bear factors

Swing to net loss in Q3 2026

Q3 2026 revenue fell 20.5% from the prior quarter to KRW 12.2 billion, and operating profit fell 50.3% to KRW 1.89 billion. The controlling-shareholder result turned to a net loss of KRW 2.03 billion.

Because operating profit stayed positive while net income turned negative, non-operating items and tax effects need to be separated out.

Revenue decline and quarterly earnings swings

Revenue in 2025 was KRW 51.6 billion, down 14.9% year on year. In Q4 2025 revenue rose to KRW 15.5 billion, yet operating profit fell 37.2% to KRW 467 million and controlling-shareholder net income was only KRW 108 million. Revenue and profit have not moved in the same direction, which makes the earnings trend harder to read.

Concentrated business and unclear sector link

Monofilament material accounts for about 60% of sales, which leaves the company dependent on toothbrush bristle demand and client orders. The exchange classifies the stock under secondary batteries, but the disclosed business centers on oral-care materials. Whether healthcare and fashion accessories growth reduces this concentration remains the key question.

10

Risk factors

Client and demand concentration

Monofilament materials and the healthcare segment are tied to global clients and toothbrush OEM makers. A reduction in client orders could affect revenue and utilization at the same time. The revenue share of individual clients is a point to check in the major-customer disclosure of the annual report.

Earnings volatility

Quarterly controlling-shareholder net income moved from KRW 1.47 billion in Q3 2025 to KRW 108 million in Q4 2025, KRW 3.13 billion in Q1 2026 and KRW 5.34 billion in Q2 2026, before a net loss of KRW 2.03 billion in Q3 2026. Quarterly operating margins also vary, so annual figures alone do not show the trend. Whether non-operating items and tax costs drive quarterly profit is the question to examine.

Gap between sector classification and business

The exchange classifies the stock under secondary batteries, but the disclosed business is oral-care materials. Even if battery-materials conditions improve, the disclosed business mix offers weak grounds for a direct effect on this company's earnings. Sector index movements and this company's earnings trend should not be treated as the same thing.

11

What to watch next

  1. Around mid-February 2027

    Q4 2026 preliminary results. The timing reflects the precedent of the 2025 annual preliminary figures disclosed on February 12, 2026. The key is whether the operating margin recovers from Q3 2026 levels.

  2. Around late March 2027

    Filing of the 2026 annual report and the annual general meeting. The 2026 AGM was held on March 31, 2026. Segment revenue, major clients and annual controlling-shareholder net income will be confirmed in the filing.

  3. Around mid-May 2027

    Filing of the Q1 2027 quarterly report, due within 45 days after the quarter ends. The focus is whether the non-operating items behind the Q3 2026 net loss normalize.

12

Overall view

Best Bristle Company is an oral-care materials company centered on toothbrush bristles, with healthcare and fashion accessories added. Operating profit rose for three consecutive years from 2023 through 2025, and the operating margin climbed from 4.2% to 12.0%.

The balance sheet is stable, with a debt-to-equity ratio of 15.2% at the end of 2025. On the other side, revenue fell 14.9% in 2025, and in Q3 2026 the company posted a controlling-shareholder net loss of KRW 2.03 billion even though operating profit remained positive.

Controlling-shareholder net income over the last four quarters totals KRW 6.54 billion, but quarterly swings are wide. The exchange classifies the stock under secondary batteries, yet the disclosed business centers on oral-care materials, so battery-industry conditions do not explain its earnings well.

The next checkpoints are the Q4 2026 preliminary results, the 2026 annual report and the Q1 2027 quarterly report, and the key tests are whether the operating margin recovers and whether non-operating items normalize.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. vegannews.co.kr
  2. files-scs.pstatic.net
  3. thevc.kr
  4. m.news.nate.com
  5. m.news.nate.com
  6. edaily.co.kr
  7. edaily.co.kr
  8. alphasquare.co.kr
  9. edaily.co.kr
  10. digitaltoday.co.kr
  11. kind.krx.co.kr
  12. marketin.edaily.co.kr
  13. news.nate.com
  14. kind.krx.co.kr
  15. awakeplus.co.kr
  16. hankyung.com
  17. imfnsec.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis